Biopharma Co. Accused Of Lying To Investors About FDA Hold
By Emilie Ruscoe · August 8, 2022, 8:15 PM EDT
An investor in biotherapeutics company Kiromic BioPharma Inc. has launched a proposed class action accusing the company and its leadership of touting prospects for two drug candidates ahead of a 2021...
To view the full article, register now.